# SinoMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sinomed

- Industry: Medical Devices & Equipment
- Headquarters: Tianjin, China
- Website: www.sinomed.net
- Latest round: Series C (Jun 1, 2007)
- Investors on record: 2

## About

Established in 2007 and based in Tianjin, China, SinoMed operates as a medical device manufacturer that mainly provides interventional medical devices. It has subsidiaries in Beijing, Suzhou, Hong Kong, the United States, Japan, and France. The company has obtained more than 200 patents. In July 2017, it raised CNY 300 million in strategic investment from new investors Beijing Nine Three investment, China Capital Management, CITIC Goldstone Fund Management, Co-Stone Venture Capital, Daoyuan Capital Management (Beijing) and Guangzhou Da'an Jinghan Investment. In October 2019, SinoMed was listed on the Shanghai Stock Exchange.

The company mainly provides interventional medical device. Products include coronary stent systems, balloon dilatation catheters, and other products. Coronary stent systems include HT Supreme™ drug-eluting stent system and HT Infinity drug-eluting stent system. Balloon dilatation catheters include NC Rockstar non-compliant coronary balloon dilatation catheter, Tradent™ Trident™ spinous process balloon dilatation catheter, and SCHONKYTONK coronary balloon dilatation catheter. Products can be used in cardiovascular, cerebrovascular, structural heart disease and other fields.

The company generates revenue by providing interventional medical device such as coronary stent systems and balloon dilatation catheters.

## Funding rounds

- Series C, Jun 1, 2007 — Japan Asia Investment Company, China Renaissance Capital Investment

## Investors

- Japan Asia Investment Company (https://capitalatlas.ai/funds/japan-asia-investment-company) — Series C
- China Renaissance Capital Investment (https://capitalatlas.ai/funds/china-renaissance-capital-investment) — Series C